Non-Aspirin NSAID Use Associated With Shorter Survival in Metastatic RCC

Metastatic renal cell carcinoma (mRCC) patients who use non-aspirin NSAIDs have poorer overall survival than aspirin users and NSAID non-users, according to a new pooled retrospective analysis.

Source: CancerNetwork - November 21, 2016 Category: Cancer & Oncology Authors: Dave Levitan Tags: Genitourinary Cancers Conferences/IKCS 2016 Kidney Cancer News Renal Cell Carcinoma Source Type: news